According to Jubilant Pharmova's latest financial reports the company has $0.13 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $0.12 B | -3.55% |
2022-03-31 | $0.12 B | 39.28% |
2021-03-31 | $93.32 M | -50.19% |
2020-03-31 | $0.18 B | -5.53% |
2019-03-31 | $0.19 B | 386.47% |
2018-03-31 | $40.76 M | -43.36% |
2017-03-31 | $71.98 M | 30.44% |
2016-03-31 | $55.18 M | -12.5% |
2015-03-31 | $63.06 M | -20.83% |
2014-03-31 | $79.66 M | 22.18% |
2013-03-31 | $65.2 M | 24.98% |
2012-03-31 | $52.16 M | -77.73% |
2011-03-31 | $0.23 B | 108.39% |
2010-03-31 | $0.11 B | 49.6% |
2009-03-31 | $75.15 M | -42.76% |
2008-03-31 | $0.13 B | -35.2% |
2007-03-31 | $0.20 B | 549.37% |
2006-03-31 | $31.2 M | 262.2% |
2005-03-31 | $8.61 M | 64.15% |
2004-03-31 | $5.24 M |